Sildenafil Tablet
Product Images NDC 69097-953

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 69097-953). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-30count.jpg (100mg 30ct)

Sildenafil Tablets, USP 100 mg oral tablet label by Cipla USA Inc. The label shows a 30-tablet package, with storage instructions at 25°C and excusions from 15-30°C. It includes manufacturer and distributor information, barcode, and a QR code. The product is Rx only.*

FDA Label Image

25mg-30ct.jpg (25mg 30ct)

Label for Sildenafil Tablets USP 25 mg, provided in a 30-tablet package. The label states it is prescription only and includes storage instructions to keep at 25°C with permitted excursions. Manufactured by Appco Pharma LLC and distributed by Cipla USA Inc. The label contains barcodes, lot, batch, expiration, and serial numbers in a separate section.*

FDA Label Image

50mg-30ct.jpg (50mg 30ct)

Label for Sildenafil Tablets USP 50 mg oral tablets, packaged as 30 tablets. The label includes dosing guidance to see prescribing information, storage conditions at 25°C with permitted excursions, and manufacturer and distributor details: manufactured by Appco Pharma LLC and distributed by Cipla USA Inc. Barcode and product NDC 69097-952-02 are visible.*

FDA Label Image

Fig-6.jpg (Fig 6)

Two bar charts illustrating the effect of Sildenafil tablets and placebo on maintenance of erection by baseline score. The charts show percentages of patients at endpoint across baseline scores 0 to 5, with different bar shades representing scores 0 through 5. The sildenafil chart shows higher percentages in bars corresponding to higher scores as baseline scores increase, while placebo bars are more varied and lower overall.*

FDA Label Image

Fig5 (Fig5)

A line graph depicting plasma concentration (ng/mL) of sildenafil over time (hours) following administration of a commercial tablet. The graph shows a peak concentration shortly after dosing with a gradual decline to near zero by 24 hours post dose.*

FDA Label Image

Figure-7.jpg (Figure 7)

A bar chart displaying the percentage of patients reporting improvement across different treatment groups: placebo, sildenafil tablets 25 mg, 50 mg, and 100 mg. The percentages increase with dosage, from 24% for placebo to 82% for 100 mg sildenafil tablets. The chart includes sample sizes for each group and an overall treatment p-value less than 0.0001.*

FDA Label Image

Figure1 (Figure1)

A line graph showing changes in systolic blood pressure (mmHg) over 24 hours after dosing, comparing sildenafil 100 mg with placebo. The x-axis represents time post dose (hours) while the y-axis measures systolic blood pressure. Data points track the blood pressure response for both sildenafil and placebo groups across the timeline.*

FDA Label Image

Figure2 (Figure2)

A line graph depicting change in SBP (mmHg) over time postdose in hours, comparing two treatments: Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The graph shows trends in blood pressure changes for each treatment over an 8-hour period.*

FDA Label Image

Figure3 (Figure3)

A line graph displaying change in blood pressure (mmHg) over time (hours) post-dose, comparing Doxazosin plus Placebo versus Doxazosin plus Sildenafil 50 mg. The x-axis represents time from 0 to 8 hours, and the y-axis shows blood pressure change ranging from approximately -50 to 40 mmHg, depicting differing trends for each treatment group.*

FDA Label Image

Figure4 (Figure4)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing changes in mmHg over time up to 8 hours after dosing. The graph compares two groups: Doxazosin plus Sildenafil 100 mg and Doxazosin plus Placebo, depicted with separate lines. The y-axis represents blood pressure change in mmHg, the x-axis time after dosing in hours.*

FDA Label Image

Str (Structure)

Chemical structure diagram of Sildenafil, displaying its molecular framework with various chemical groups including ethyl, methyl, and carboxyl components. The image illustrates the compound's detailed atomic connections.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.